Phase 1 Coronary Artery Disease Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1
A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease
stable coronary artery diseaseHealthy Volunteers
Hoffmann-La Roche196 enrolled1 locationNCT07495813
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients
Myocardial IschemiaCoronary Artery Disease
GE Healthcare54 enrolled5 locationsNCT04604782
Recruiting
Phase 1Phase 2
A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease
Coronary Heart DiseaseCoronary Artery DiseaseAtheroscleroses
Xia Liang30 enrolled1 locationNCT07493603
Recruiting
Phase 1
Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG)
Coronary microvascular diseaseCoronary Microvascular Dysfunction (CMD)Angina Patients With Non-obstructive Coronary Artery Disease
University of Virginia150 enrolled1 locationNCT06600178
Completed
Phase 1
Drug-Eluting Stent Study Evaluating a New Technology in Patients with Symptomatic Ischemic Heart Disease due to Coronary Artery Blockage
Symptomatic Ischemic Heart DiseaseCoronary Artery Disease
Svelte Medical Systems, Inc.30 enrolled3 locationsACTRN12611001131943